The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -63.46%. However, over the past six months, we’ve seen a stronger performance of -49.98%. The price of RENB leaped by -9.11% over the last 30 days. And in the last five days, it has fallen by -4.59%.
The stock market performance of Renovaro Inc has been fairly unsteady.
52-week price history of RENB Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Renovaro Inc’s current trading price is -86.95% away from its 52-week high, while its distance from the 52-week low is 10.82%. The stock’s price range for this period has been between $0.28 and $2.34. The Healthcare sector company’s shares saw a trading volume of about 71.35 million for the day, which was higher than the average daily volume of 1.0 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Renovaro Inc (RENB) has experienced a quarterly decline of -63.95% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 52.55M and boasts a workforce of 25 employees.
How Moving Averages and Trading Volume Data Work Together
RENB’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for RENB stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.01.
